We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lab-on-a-Chip Nanotechnology Tracks Multiple Markers

By LabMedica International staff writers
Posted on 03 Jul 2017
Research engineers have invented a technology for nanoelectronic barcoding of microparticles that could be used in wearable or hand-held devices to analyze body fluids, such as sweat or blood, for various biomarkers or pollutants simultaneously.

The team, led by Mehdi Javanmard, assistant professor at Rutgers University-New Brunswick (New Brunswick, NJ), invented the biosensor technology to better monitor health and exposure to pathogenic microorganisms as well as to pollutants.

“This is really important in the context of personalized medicine or personalized health monitoring,” said Prof. More...
Javanmard, “Our technology enables true labs on chips. We’re talking about platforms the size of a USB flash drive or something that can be integrated [into a fitness watch].”

In recent decades, research on biomarkers has revealed the complex nature of the molecular mechanisms behind human disease. That has heightened the importance of testing bodily fluids for numerous biomarkers simultaneously, the authors said.
“One biomarker is often insufficient to pinpoint a specific disease because of the heterogeneous nature of various types of diseases,” said Prof. Javanmard, “To get an accurate diagnosis and accurate management of various health conditions, you need to be able to analyze multiple biomarkers at the same time.”

Bulky optical instruments are the state-of-the-art technology for detecting and measuring biomarkers, but are too large to add to a portable device. Electronic detection of microparticles allows for ultra-compact instruments needed for wearable devices. The researchers’ technique for barcoding particles to identify them is, for the first time, fully electronic, allowing biosensors to be shrunk to the size of a wearable band or a microchip, the authors said.

The technology was greater than 95% accurate in identifying tested biomarkers, and fine-tuning is underway to make it 100% accurate, said Prof. Javanmard. The team is also working on portable detection of microrganisms, including pathogenic bacteria and viruses. “Imagine a small tool that could analyze a swab sample of what’s on the doorknob of a bathroom or front door and detect influenza or a wide array of other virus particles,” he said, “Imagine ordering a salad at a restaurant and testing it for E. coli or Salmonella bacteria.” This form of the tool could be commercially available within about two years, while health monitoring and diagnostic tools could be available within about five years, he said.

The study, by Xie P et al, was published April 28, 2017, in the journal Lab on a Chip.

Related Links:
Rutgers University-New Brunswick


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
PSA Test
Humasis PSA Card
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.